You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PCRX Exercise Disclosure
Riker Lauren · SEC Form 4 · Filed Oct 9, 2026
Exercise
Calculated transaction value
$0
Riker Lauren Senior Vice President, Finance
PCRX
Pacira BioSciences
PCRX
Transaction date
Oct 8, 2026
Public filing date
Oct 9, 2026
Filing lag
Filed 1 day later
PCRX daily price context
Close on/before transaction
$36.39
Oct 8, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 6,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-065566
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$412.02K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Pacira Biosciences, Inc. PCRX | Sale | Oct 8, 2026 | $217.92K |
| Pacira Biosciences, Inc. PCRX | Exercise | Oct 8, 2026 | $194.1K |
| Pacira Biosciences, Inc. PCRX Current | Exercise | Oct 8, 2026 | $0 |